Three passive institutional investors have now fully exited FBRX within weeks. Monitor for additional institutional selling and any potential conversion of remaining 13G filers to 13D activist filings.
Price Chart
How similar events traded
Executive Summary
Affinity Asset Advisors, LLC filed an amendment to Schedule 13G reporting a complete exit from Forte Biosciences, reducing its beneficial ownership to 0 shares (0.00%) as of September 30, 2026. This follows similar full exits by MPM BioImpact and Tybourne Capital Management in recent weeks, showing a pattern of passive institutional liquidation.
Key Financial Metrics
Key Facts
- Affinity Asset Advisors reduced its stake to 0 shares as of September 30, 2026
- Affinity now owns 0.0% of Forte Biosciences common stock
- This is the third passive institutional exit from FBRX in recent weeks, following MPM BioImpact and Tybourne Capital Management
- Filing is an amendment to Schedule 13G, indicating passive investor status
Financial Impact
Complete exit by Affinity Asset Advisors; prior stake size not disclosed in this filing
Risk Factors
- Pattern of institutional exits may signal deteriorating fundamentals or loss of confidence
- Remaining passive holders may also reduce or exit positions
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| SC 13G/A Filing (Primary) | 0001011438-26-000693 |
| Document: 0001011438-26-000693-index.html | 0001011438-26-000693 |
| Document: 0001011438-26-000693.txt | 0001011438-26-000693 |
Track record
15 reports on FBRX
2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +39.79% at T+60 after the Apr 8, 2026 report. 4 of 7 went positive at some point.
Filters
- Nov 13, 20263d ago SC 13G/A Bearish 5/10 Viewing Entry price pending
- Nov 13, 20263d ago SC 13G/A Bearish 5/10 Entry price pending
- Nov 4, 202612d ago SC 13G/A Bearish 4/10 No price data
- Sep 2, 202610w ago EFFECT Bearish 7/10 Entry $76.99 settles Nov 27
- Sep 2, 202610w ago EFFECT Bearish 6/10 Entry $76.99 settles Nov 27
- Aug 27, 202611w ago 25-NSE Bearish 9/10 Entry $76.99 settles Nov 20
- Jul 27, 202616w ago 8-K Bullish 8/10 Entry $76.50 No price data
- Jun 11, 202622w ago EFFECT Bearish 6/10 Entry $17.40 No price data
- Jun 5, 202623w ago S-3/A Bearish 6/10 Entry $15.67 No price data
- Jun 2, 202623w ago S-3 Bearish 6/10 Entry $17.00 to $76.99 ▼ −352.88% −350.38% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers